# Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy

> **NCT01078363** · NA · COMPLETED · sponsor: **Stanford University** · enrollment: 96 (actual)

## Conditions studied

- Cardiac Allograft Vasculopathy

## Interventions

- **DRUG:** ramipril
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01078363
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2017-01-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01078363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01078363, "Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01078363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*